BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15870430)

  • 1. RNA-based nanoparticle treatment shows promise in Ewing's sarcoma model.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):627. PubMed ID: 15870430
    [No Abstract]   [Full Text] [Related]  

  • 2. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
    Hu-Lieskovan S; Heidel JD; Bartlett DW; Davis ME; Triche TJ
    Cancer Res; 2005 Oct; 65(19):8984-92. PubMed ID: 16204072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context matters: the hen or egg problem in Ewing's sarcoma.
    Kovar H
    Semin Cancer Biol; 2005 Jun; 15(3):189-96. PubMed ID: 15826833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
    Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
    Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
    Filion C; Labelle Y
    Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
    Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
    Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.
    Liu XF; Helman LJ; Yeung C; Bera TK; Lee B; Pastan I
    Cancer Res; 2000 Sep; 60(17):4752-5. PubMed ID: 10987281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular origin of Ewing's tumor. A corner of the veil is lifted].
    Tirode F; Laud-Duval K; Delattre O
    Med Sci (Paris); 2008 Mar; 24(3):248-50. PubMed ID: 18334171
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
    Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
    Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
    Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
    Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
    Coles EG; Lawlor ER; Bronner-Fraser M
    Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewings family oncoproteins: drunk, disorderly and in search of partners.
    Lee KA
    Cell Res; 2007 Apr; 17(4):286-8. PubMed ID: 17426699
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
    Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
    Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
    Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
    Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment for Ewing's sarcoma.
    Thacker MM; Temple HT; Scully SP
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.